 |
 Video: What is a Stock Split?
|
|
|
| Sight Sciences is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Co.'s Surgical Glaucoma segment's product portfolio features the OMNI® Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Co.'s Dry Eye segment's product portfolio consists of the TearCare® system for ophthalmologists and optometrists. TearCare is a wearable eyelid technology. According to our Sight Sciences stock split history records, Sight Sciences has had 0 splits. | |
|
Sight Sciences (SGHT) has 0 splits in our Sight Sciences stock split history database.
Looking at the Sight Sciences stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sight Sciences shares, starting with a $10,000 purchase of SGHT, presented on a split-history-adjusted basis factoring in the complete Sight Sciences stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/16/2021 |
|
| End date: |
04/29/2024 |
|
| Start price/share: |
$32.70 |
|
| End price/share: |
$5.82 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-82.20% |
|
| Average Annual Total Return: |
-46.15% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,779.37 |
|
| Years: |
2.79 |
|
|
|
|
|
